Astrana Health Analyst Price Targets - Benzinga

Astrana Health Inc

ASTHNASDAQ

Trade with Public

Trade with Public

$37.20

-0.25-0.67%

Ult. Agg.: Oct 26, 3:02 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Astrana Health Analyst Price Targets - Benzinga

Astrana Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Astrana Health (ASTH).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

11Buy

Consensus RatingBuy# Analysts11Avg. Consensus PT$50Upside to Avg. PT+34.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 1, 2026	Freedom Capital Markets	Gene Mannheimer	Maintained	Buy	$50
Sep 15, 2026	Oppenheimer	Michael Wiederhorn	Initiate	Outperform	$53
Aug 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$47→$55
Aug 7, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$50→$53
Jul 14, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$45→$50
Jul 14, 2026	BTIG	David Joyce	PT Raise	Buy	$50→$65
Jun 2, 2026	BTIG	David Larsen	Maintained	Buy	$50
May 26, 2026	Barclays	Andrew Mok	Upgrade	Equal-Weight→Overweight	$37→$50
May 14, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$38→$47
May 12, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$35→$45
May 11, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$26→$37
May 8, 2026	BTIG	David Larsen	PT Raise	Buy	$40→$50
May 8, 2026	Needham	Matthew Shea	PT Raise	Buy	$30→$41
Apr 15, 2026	Baird	Michael Ha	PT Raise	Outperform	$37→$40
Mar 13, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$37→$38
Feb 2, 2026	BTIG	David Larsen	PT Cut	Buy	$45→$40
Dec 12, 2025	Needham	Matthew Shea	Initiate	Buy	$28
Nov 25, 2025	Jefferies	Jack Slevin	PT Cut	Buy	$44→$37
Nov 24, 2025	Barclays	Andrew Mok	PT Cut	Equal-Weight	$36→$26
Nov 10, 2025	TD Cowen	Ryan Langston	PT Cut	Buy	$40→$35

Analyst Ratings News

PRO
Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53

Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53

Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50

TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Astrana Health, Raises Price Target to $65

BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $50 to $65.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target

BTIG analyst David Larsen reiterates Astrana Health (NASDAQ:ASTH) with a Buy and maintains $50 price target.

Benzinga Newsdesk